Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amlodipine 2.5mg/5ml oral suspension
0206020A0AAAJAJ
|
Amlodipine | Amlodipine | Cardiovascular System | No data available |
|
Amlodipine 2mg/5ml oral liquid
0206020A0AAANAN
|
Amlodipine | Amlodipine | Cardiovascular System | No data available |
|
Amlodipine 4mg/5ml oral liquid
0206020A0AAAGAG
|
Amlodipine | Amlodipine | Cardiovascular System | No data available |
|
Amlodipine 50mg/5ml oral liquid
0206020A0AAAFAF
|
Amlodipine | Amlodipine | Cardiovascular System | No data available |
|
Amlostin 10mg tablets
0206020A0BFABAB
|
Amlostin | Amlodipine | Cardiovascular System | No data available |
|
Ammonaps 500mg tablets
0908010P0BCAAAG
|
Ammonaps | Sodium phenylbutyrate | Nutrition and Blood | No data available |
|
Ammonaps 940mg/g granules
0908010P0BCABAH
|
Ammonaps | Sodium phenylbutyrate | Nutrition and Blood | No data available |
|
Ammonia and Ipecacuanha mixture
0309020B0AAACAC
|
Ammon bicarbonate | Ammonium bicarbonate | Respiratory System | No data available |
|
Ammonia solution aromatic
190500000AAAAAA
|
Generic compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
Ammonia solution dilute
190400000AAGGGG
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Ammonia solution strong
190400000AAGJGJ
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Ammonia solution strong 3.5% liquid
190400000AAUIUI
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Ammonium acetate solution strong
0309020A0AAAAAA
|
Ammon acetate | Ammonium acetate | Respiratory System | No data available |
|
Ammonium bicarbonate powder
190400000AAHBHB
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Ammonium chloride 325mg / Caffeine 100mg gast res tab
070403000AAAFAF
|
Generic compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ammonium chloride mixture sugar free
0704030C0AAABAB
|
Ammonium chloride | Ammonium chloride | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ammonium chloride powder
190400000AAHEHE
|
Generic compound preparation BNF 1904000 | Other single substance preparations | Other Drugs and Preparations | No data available |
|
Ammonium sulfate 500mg capsules
190500000AAACAC
|
Generic compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
Ammonium sulfate 500mg tablets
190500000AABKBK
|
Generic compound preparation BNF 1905000 | Other preparations | Other Drugs and Preparations | No data available |
|
Amnivent-225 SR tablets
0301030B0BDAAAR
|
Amnivent-225 | Aminophylline | Respiratory System | No data available |
|
Amobarbital 50mg tablets
0401030C0AAACAC
|
Amobarbital | Amobarbital | Central Nervous System | No data available |
|
Amoram 125mg/5ml oral suspension
0501013B0BGACAS
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 250mg capsules
0501013B0BGAAAA
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 250mg/5ml oral suspension
0501013B0BGADAT
|
Amoram | Amoxicillin | Infections | No data available |
|
Amoram 500mg capsules
0501013B0BGABAB
|
Amoram | Amoxicillin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.